Johnson Pharmacare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	-	-	-	25.27	32.63
Other Revenue	15.81	-	-	-	-
Revenue	15.81	-	-	25.27	32.63
Revenue Growth (YoY)	-	-	-	-22.56%	329.37%
Cost of Revenue	-	-	-	20.22	26.92
Gross Profit	15.81	-	-	5.05	5.71
Selling, General & Admin	0.18	0.13	0.06	0.75	1.27
Other Operating Expenses	427.65	9.04	1.91	1.97	2.99
Operating Expenses	427.83	9.17	1.96	2.72	4.26
Operating Income	-412.02	-9.17	-1.96	2.33	1.45
Interest Expense	-2.62	-	-	-	-
EBT Excluding Unusual Items	-414.64	-9.17	-1.96	2.33	1.45
Gain (Loss) on Sale of Investments	-	3.33	-	-15.52	-
Other Unusual Items	-142.7	-	-	-	-
Pretax Income	-557.34	-5.84	-1.96	-13.19	1.45
Income Tax Expense	-	-	-	-0.27	0.48
Net Income	-557.34	-5.84	-1.96	-12.91	0.97
Net Income to Common	-557.34	-5.84	-1.96	-12.91	0.97
Net Income Growth	-	-	-	-	8135.39%
Shares Outstanding (Basic)	552	550	550	550	550
Shares Outstanding (Diluted)	552	550	550	550	550
Shares Change (YoY)	0.33%	-	-	-	-
EPS (Basic)	-1.01	-0.01	-0.00	-0.02	0.00
EPS (Diluted)	-1.01	-0.01	-0.00	-0.02	0.00
EPS Growth	-	-	-	-	8271.43%
Gross Margin	100.00%	-	-	20.00%	17.49%
Operating Margin	-2606.07%	-	-	9.23%	4.44%
Profit Margin	-3525.23%	-	-	-51.11%	2.96%
EBIT	-412.02	-9.17	-1.96	2.33	1.45
EBIT Margin	-	-	-	9.23%	4.44%
Effective Tax Rate	-	-	-	-	33.31%
Revenue as Reported	15.81	-	-	25.27	32.63